References
Cohen, J., Donnelly, J. P., Worsley, A. M., Catovsky, D., Goldman, J. M., Galton, D. A. G. Septicemia caused by viridans streptococci in neutropenic patients with leukemia. Lancet ii (1983) 1452–1454.
Brown, A. E. Neutropenia, fever, and infection. Am. J. Med. 76 (1984) 421–428.
Henslee, J., Bostrom, B., Weisdorf, D., Ramsay, N., McGlove, P., Kersey, J. Streptococcal sepsis in bone marrow transplant patients. Lancet i (1984) 393.
Kern, W., Kurrle, E., Vanek, E. High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia. Klin. Wochenschr. 65 (1987) 773–780.
Menichetti, F., Del Favero, A., Guerciolini, R., Tonato, M., Frongillo, R. F., Roila, F., Pauluzzi, S. Viridans streptococci septicemia in cancer patients: a clinical study. Eur. J. Epidemiol. 3 (1987) 316–318.
Maschmeyer, G., Rosenthal, E., Wendt, F. Bacteriological surveillance during long-term administration of 4-quinolones. Rev. Infect. Dis. 11 (1989) (Suppl. 5) S1238-S1239.
Langley, J., Gold, R. Sepsis in febrile neutropenic children with cancer. Pediatr. Infect. Dis. J. 7 (1988) 34–37.
Venditti, M., Baiocchi, P., Cantini, C., Brandimarte, C., Serra, P., Gentile, G., Girmenia, C., Martino, P. Antimicrobial susceptibilities ofStreptococcus species that cause septicemia in neutropenic patients. Antimicrob. Agents Chemother. 33 (1989) 580–582.
Kern, W., Kurrle, E., Vanek, E. Ofloxacin for prevention of bacterial infections in granulocytopenic patients. Infection 15 (1987) 427–432.
Karp, J. E., Merz, W. G., Hendricksen, C., Laughon, T., Redden, B., Bamberger, J., Bartlett, J., Saral, R., Burke, P. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. Ann. Int. Med. 106 (1987) 1–7.
Facklam, R. R., Carey, R. B.: Streptococci and aerococci. In:Lennette, E. H., Balows, A., Hausler, W. J. Jr., Shadomy, H. J. (eds.): Manual of Clinical Microbiology, 4th ed. American Society for Microbiology, 1985, pp. 154–175.
Sun, Z. M., Maskell, J. P., Sehgal, S. C., Williams, J. D.: In vitro activity of Iomefloxacin and other quinolones. Rev. Infect. Dis. 11 (1989) (Suppl. 5) S930.
Fernandez-Roblas, R., Jimenez-Arriero, M., Romero, M., Soriano, F. In vitro activity of quinolones and other agents against problematic gram-positive pathogens. Rev. Infect. Dis. 11 (1989) (Suppl. 5) S931–933.
Rozenberg-Arska, M., Dekker, A., Verdonck, L., Verhoef, J. Prevention of bacteremia caused by α-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin. Infection 17 (1989) 240–244.
Guiot, H. F. K., van den Broek, P. J., van der Meer, J. W. M., Peters, W. G., Willemze, R., van Furth, R. The association between streptococcal infection and interstitial pneumonia in chemotherapy and BMT. Bone Marrow Transplant 3 (1988) (Suppl. 1) 274.
Van Furth, R., Guiot, H. F. L. Modulation of the host flora. Eur. J. Clin. Microbiol. Infect. Dis. 8 (1989) 1–7.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kern, W., Linzmeier, K. & Kurrle, E. Antimicrobial susceptibility of viridans group streptococci isolated from patients with acute leukemia receiving ofloxacin for antibacterial prophylaxis. Infection 17, 396–397 (1989). https://doi.org/10.1007/BF01645556
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01645556